A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving ...

Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...

Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...

Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...

Pulmonary hypertension (PH) is a chronic and progressive disease associated with high blood pressure in the blood vessels that supply the lungs, known as the pulmonary arteries. Read more about PH ...

Mutations in certain genes can cause or increase the likelihood of someone developing PAH. This is known as familial or heritable PAH.

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary arterial hypertension (PAH) is a rare type of pulmonary hypertension that can be the result of one of several causes, or by no apparent cause. Read more information about PAH here.

Read about the various types of pulmonary hypertension, and their causes, as classified by the World Health Organization (WHO).

Pulmonary hypertension (PH) is rare, life-threatening lung disorder that affects the pulmonary arteries, which are responsible for transporting the blood from the right heart ventricle to the lungs.

Some of the common symptoms of pulmonary hypertension include shortness of breath, excessive fatigue, weakness, chest pain, and fainting.